HER2/neu vaccines in breast cancer

Author： Khoo Steven   Ponniah Sathibalan   Peoples George E  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.2, 2006-03, pp. : 217-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J.   Ricci Jr. Andrew  

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

Targeting Her-2/neu in Breast Cancer: As Easy as This!

By  

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 150-157

Karger

Access to resources Recommend Favorite

Her-2/neu Overexpression Due to Polysomy 17 in Breast Cancer: Molecular Testing to Guide Therapeutic Options

By  

Oncology Research and Treatment, Vol. 34, Iss. 7, 2011-06 ,pp. : 356-360

Karger

Access to resources Recommend Favorite

Change in HER-2/neu Status from Negative to Positive following Treatment in Breast Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-01 ,pp. : 19-24

Karger

Access to resources Recommend Favorite

What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer

By Trosman Julia R   Weldon Christine B   Schink Julian C   Gradishar William J   Benson Al B  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 4, 2013-07 ,pp. : 461-477

Future Medicine

Access to resources Recommend Favorite